Literature DB >> 21157184

The Parkinson disease protein α-synuclein inhibits autophagy.

Ashley R Winslow1, David C Rubinsztein.   

Abstract

Parkinson disease (PD) is the most common movement disorder affecting people. It is characterized by the accumulation of the protein α-synuclein in Lewy body inclusions in vulnerable neurons. α-Synuclein overexpression caused by gene multiplications is sufficient to cause this disease, suggesting that α-synuclein accumulation is toxic. Here we review our recent study showing that α-synuclein inhibits autophagy. We discuss our mechanistic understanding of this phenomenon and also speculate how a deficiency in autophagy may contribute to a range of pleiotropic features of PD biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21157184      PMCID: PMC3127221          DOI: 10.4161/auto.7.4.14393

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  α-Synuclein impairs macroautophagy: implications for Parkinson's disease.

Authors:  Ashley R Winslow; Chien-Wen Chen; Silvia Corrochano; Abraham Acevedo-Arozena; David E Gordon; Andrew A Peden; Maike Lichtenberg; Fiona M Menzies; Brinda Ravikumar; Sara Imarisio; Steve Brown; Cahir J O'Kane; David C Rubinsztein
Journal:  J Cell Biol       Date:  2010-09-20       Impact factor: 10.539

  1 in total
  44 in total

1.  Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.

Authors:  Taeyeon Kim; Elvira Valera; Paula Desplats
Journal:  Mol Neurobiol       Date:  2019-04-09       Impact factor: 5.590

2.  The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy.

Authors:  Wooyoung Jang; Hee Ju Kim; Huan Li; Kwang Deog Jo; Moon Kyu Lee; Hyun Ok Yang
Journal:  Mol Neurobiol       Date:  2015-07-09       Impact factor: 5.590

3.  Cocaine Mediated Neuroinflammation: Role of Dysregulated Autophagy in Pericytes.

Authors:  Susmita Sil; Fang Niu; Eric Tom; Ke Liao; Palsamy Periyasamy; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2018-08-27       Impact factor: 5.590

Review 4.  Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.

Authors:  E Valera; G Monzio Compagnoni; E Masliah
Journal:  Neuropathol Appl Neurobiol       Date:  2016-02       Impact factor: 8.090

5.  Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.

Authors:  Zhenwei Yu; Min Shi; Tessandra Stewart; Pierre-Olivier Fernagut; Yang Huang; Chen Tian; Benjamin Dehay; Anzari Atik; Dishun Yang; Francesca De Giorgi; François Ichas; Marie-Hélène Canron; Roberto Ceravolo; Daniela Frosini; Han-Joon Kim; Tao Feng; Wassilios G Meissner; Jing Zhang
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

Review 6.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.

Authors:  Xiao-Su Gu; Fen Wang; Cai-Yi Zhang; Cheng-Jie Mao; Jing Yang; Ya-Ping Yang; Sha Liu; Li-Fang Hu; Chun-Feng Liu
Journal:  Neurochem Res       Date:  2016-07-22       Impact factor: 3.996

8.  Identification of key pathways and transcription factors related to Parkinson disease in genome wide.

Authors:  Bin Zhang; Cuiping Xia; Qunfeng Lin; Jie Huang
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

Review 9.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

Review 10.  Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson's disease: potential therapeutic targets?

Authors:  Tian-Fang Jiang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2012-09-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.